Stock News

Sphera Funds Management LTD Has Decreased Cytokinetics (Call) (CYTK) Position by $1.65 Million; As Dollar General (DG) Market Value Declined, Capital International Investors Has Upped Holding

Sphera Funds Management Ltd decreased its stake in Cytokinetics Inc (Call) (CYTK) by 54.13% based on its latest 2017Q3 regulatory filing with the SEC. Sphera Funds Management Ltd sold 117,990 shares as the company’s stock rose 26.22% with the market. The institutional investor held 100,000 shares of the health care company at the end of 2017Q3, valued at $1.45 million, down from 217,990 at the end of the previous reported quarter. Sphera Funds Management Ltd who had been investing in Cytokinetics Inc (Call) for a number of months, seems to be less bullish one the $432.43 million market cap company. The stock decreased 7.23% or $0.625 during the last trading session, reaching $8.025. About 785,875 shares traded or 5.44% up from the average. Cytokinetics, Incorporated (NASDAQ:CYTK) has risen 88.33% since February 17, 2017 and is uptrending. It has outperformed by 71.63% the S&P500.

Capital International Investors increased its stake in Dollar General Corp (DG) by 14.04% based on its latest 2017Q3 regulatory filing with the SEC. Capital International Investors bought 791,600 shares as the company’s stock declined 7.36% while stock markets rallied. The institutional investor held 6.43 million shares of the department and specialty retail stores company at the end of 2017Q3, valued at $520.99M, up from 5.64 million at the end of the previous reported quarter. Capital International Investors who had been investing in Dollar General Corp for a number of months, seems to be bullish on the $26.54 billion market cap company. The stock decreased 0.73% or $0.72 during the last trading session, reaching $97.73. About 1.79M shares traded. Dollar General Corporation (NYSE:DG) has declined 12.26% since February 17, 2017 and is downtrending. It has underperformed by 28.96% the S&P500.

Sphera Funds Management Ltd, which manages about $700.90M US Long portfolio, upped its stake in Biogen Inc (NASDAQ:BIIB) by 15,000 shares to 105,000 shares, valued at $32.88 million in 2017Q3, according to the filing. It also increased its holding in Prothena Corp Plc (NASDAQ:PRTA) by 20,000 shares in the quarter, for a total of 60,000 shares, and has risen its stake in Ignyta Inc (NASDAQ:RXDX).

Among 12 analysts covering Cytokinetics (NASDAQ:CYTK), 11 have Buy rating, 0 Sell and 1 Hold. Therefore 92% are positive. Cytokinetics had 22 analyst reports since July 24, 2015 according to SRatingsIntel. H.C. Wainwright maintained the shares of CYTK in report on Friday, October 27 with “Buy” rating. The stock of Cytokinetics, Incorporated (NASDAQ:CYTK) has “Buy” rating given on Wednesday, July 27 by Needham. The stock has “Overweight” rating by Cantor Fitzgerald on Friday, December 16. The firm has “Buy” rating given on Monday, November 9 by TH Capital. The firm earned “Buy” rating on Thursday, August 3 by H.C. Wainwright. The stock of Cytokinetics, Incorporated (NASDAQ:CYTK) earned “Market Outperform” rating by JMP Securities on Wednesday, March 9. The firm earned “Outperform” rating on Tuesday, November 10 by FBR Capital. The rating was maintained by Roth Capital with “Buy” on Monday, November 9. Cowen & Co maintained the stock with “Buy” rating in Thursday, August 3 report. The stock has “Neutral” rating by Cantor Fitzgerald on Wednesday, November 22.

Since August 29, 2017, it had 0 buys, and 11 insider sales for $2.66 million activity. McDowell Caryn Gordon sold 2,709 shares worth $24,381. GAGE L PATRICK sold $72,944 worth of stock or 5,000 shares. $1.77M worth of Cytokinetics, Incorporated (NASDAQ:CYTK) was sold by Morgan Bradley Paul on Thursday, August 31. COSTA SANTO J sold $70,000 worth of Cytokinetics, Incorporated (NASDAQ:CYTK) on Tuesday, August 29.

Investors sentiment decreased to 1.39 in Q3 2017. Its down 1.55, from 2.94 in 2017Q2. It is negative, as 16 investors sold CYTK shares while 30 reduced holdings. 21 funds opened positions while 43 raised stakes. 39.12 million shares or 3.53% more from 37.79 million shares in 2017Q2 were reported. New York State Teachers Retirement Systems, a New York-based fund reported 21,592 shares. 358,713 are held by Ameriprise. 228,172 are owned by Morgan Stanley. Swiss Comml Bank has invested 0% in Cytokinetics, Incorporated (NASDAQ:CYTK). Guggenheim Cap Ltd Limited Liability Company stated it has 123,456 shares. Northern Tru stated it has 471,858 shares. Wellington Mgmt Group Llp reported 0.01% stake. Meeder Asset Mngmt reported 426 shares. Lenox Wealth Mngmt accumulated 0% or 650 shares. Granite Investment Ltd Liability Corp reported 0.04% stake. Sphera Funds has invested 0.47% of its portfolio in Cytokinetics, Incorporated (NASDAQ:CYTK). 145,506 are held by Dimensional Fund L P. Manufacturers Life Insurance The has 0% invested in Cytokinetics, Incorporated (NASDAQ:CYTK) for 32,615 shares. Blackrock Incorporated reported 0.01% in Cytokinetics, Incorporated (NASDAQ:CYTK). The Maryland-based Price T Rowe Assocs Md has invested 0% in Cytokinetics, Incorporated (NASDAQ:CYTK).

Since September 12, 2017, it had 0 insider buys, and 5 sales for $3.04 million activity. Ravener Robert D sold $866,789 worth of stock. TAYLOR RHONDA sold $251,895 worth of stock or 2,711 shares. Kindy Michael J had sold 7,536 shares worth $683,092 on Thursday, December 14.

Capital International Investors, which manages about $83.48B US Long portfolio, decreased its stake in Paychex Inc (NASDAQ:PAYX) by 3.28 million shares to 67,410 shares, valued at $4.04 million in 2017Q3, according to the filing. It also reduced its holding in Broadcom Ltd by 136,781 shares in the quarter, leaving it with 1.46M shares, and cut its stake in Altaba Inc.

Among 30 analysts covering Dollar General Corp. (NYSE:DG), 17 have Buy rating, 2 Sell and 11 Hold. Therefore 57% are positive. Dollar General Corp. had 102 analyst reports since August 13, 2015 according to SRatingsIntel. The stock has “Buy” rating by Piper Jaffray on Sunday, August 20. The firm has “Overweight” rating given on Monday, July 18 by Morgan Stanley. The rating was initiated by Oppenheimer with “Buy” on Thursday, February 1. The firm earned “Buy” rating on Friday, August 26 by UBS. The rating was maintained by M Partners on Friday, May 27 with “Buy”. Wolfe Research downgraded Dollar General Corporation (NYSE:DG) on Tuesday, November 10 to “Peer Perform” rating. Barclays Capital maintained Dollar General Corporation (NYSE:DG) on Friday, March 11 with “Equal-Weight” rating. Jefferies maintained the shares of DG in report on Friday, February 16 with “Hold” rating. The stock has “Hold” rating by Deutsche Bank on Friday, August 26. The stock of Dollar General Corporation (NYSE:DG) earned “Hold” rating by BMO Capital Markets on Thursday, June 1.

Investors sentiment decreased to 0.91 in Q3 2017. Its down 0.07, from 0.98 in 2017Q2. It dived, as 58 investors sold DG shares while 187 reduced holdings. 56 funds opened positions while 167 raised stakes. 237.14 million shares or 1.40% less from 240.50 million shares in 2017Q2 were reported. Fifth Third National Bank holds 0% or 303 shares. Strs Ohio reported 3,609 shares. Da Davidson holds 0.01% in Dollar General Corporation (NYSE:DG) or 4,492 shares. Df Dent Company, Maryland-based fund reported 2,874 shares. Brown Advisory Securities Lc has 2,884 shares for 0.05% of their portfolio. 3,754 were accumulated by Horan Cap. The Oregon-based Oregon Public Employees Retirement Fund has invested 0.08% in Dollar General Corporation (NYSE:DG). Eaton Vance Mgmt holds 27,738 shares or 0.01% of its portfolio. Sandy Spring Natl Bank accumulated 200 shares. 10,076 are owned by Homrich Berg. Seabridge Ltd Liability has 0.08% invested in Dollar General Corporation (NYSE:DG). Lvm Mgmt Mi stated it has 45,257 shares or 0.88% of all its holdings. Old Natl Savings Bank In reported 0.03% stake. Burney holds 0.03% or 5,486 shares in its portfolio. Scotia invested in 0.02% or 19,065 shares.

Leave a Reply

Your email address will not be published. Required fields are marked *